The role of dog-assisted therapy in rehabilitation, clinical recovery and improving quality of life

Not Applicable

Completed

• Conditions: Quality of life of patients with neurological and musculoskeletal disorders; Not Applicable

• Registration Number: ISRCTN10208787
• Lead Sponsor: Semmelweis University

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38867254/ (added 13/06/2024)

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-05-31
• Study Start: 2022-03-15
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 118

Inclusion Criteria

Patients aged 18 years and over with neurological and musculoskeletal disorders (e.g. stroke, multiple sclerosis, arthrosis, amputation, bone fractures)

Exclusion Criteria

1. Dog hair allergy
2. Immunosuppressed status
3. Early postoperative status
4. Age less than 18 years
4. Dementia
5. Refusal to participate in research
6. Decompensated physical and psychological status determined by the treating physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Anxiety measured using the Spielberger State Anxiety Inventory (STAI) at baseline and after the last, third therapy session<br>2. Quality of life measured using the WHO Well-Being Index (WBI) at baseline and after the last, third therapy session<br>3. General condition and the impact of the therapy on different aspects of life measured using the Illness Intrusiveness Rating Scale (IIRS) at baseline and after the last, third therapy session

Secondary Outcome Measures

Name	Time	Method
1. Depression measured using the Beck Depression Inventory (BDI-9) at baseline and after the last, third therapy session.<br>2. Pain measured using the Visual Analogue Scale (VAS) at baseline and after the last, third therapy session